345 related articles for article (PubMed ID: 20201038)
1. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children.
Monsiváis-Urenda A; Noyola-Cherpitel D; Hernández-Salinas A; García-Sepúlveda C; Romo N; Baranda L; López-Botet M; González-Amaro R
Eur J Immunol; 2010 May; 40(5):1418-27. PubMed ID: 20201038
[TBL] [Abstract][Full Text] [Related]
2. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children.
Noyola DE; Fortuny C; Muntasell A; Noguera-Julian A; Muñoz-Almagro C; Alarcón A; Juncosa T; Moraru M; Vilches C; López-Botet M
Eur J Immunol; 2012 Dec; 42(12):3256-66. PubMed ID: 22965785
[TBL] [Abstract][Full Text] [Related]
3. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.
Gumá M; Cabrera C; Erkizia I; Bofill M; Clotet B; Ruiz L; López-Botet M
J Infect Dis; 2006 Jul; 194(1):38-41. PubMed ID: 16741880
[TBL] [Abstract][Full Text] [Related]
4. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979
[TBL] [Abstract][Full Text] [Related]
5. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.
Muntasell A; Vilches C; Angulo A; López-Botet M
Eur J Immunol; 2013 May; 43(5):1133-41. PubMed ID: 23552990
[TBL] [Abstract][Full Text] [Related]
6. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus.
Muntasell A; López-Montañés M; Vera A; Heredia G; Romo N; Peñafiel J; Moraru M; Vila J; Vilches C; López-Botet M
Eur J Immunol; 2013 Dec; 43(12):3268-78. PubMed ID: 24030638
[TBL] [Abstract][Full Text] [Related]
7. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
[TBL] [Abstract][Full Text] [Related]
9. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
[TBL] [Abstract][Full Text] [Related]
10. The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.
López-Botet M; Muntasell A; Vilches C
Semin Immunol; 2014 Apr; 26(2):145-51. PubMed ID: 24666761
[TBL] [Abstract][Full Text] [Related]
11. The expression of human natural killer cell receptors in early life.
Sundström Y; Nilsson C; Lilja G; Kärre K; Troye-Blomberg M; Berg L
Scand J Immunol; 2007; 66(2-3):335-44. PubMed ID: 17635811
[TBL] [Abstract][Full Text] [Related]
12. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.
Gumá M; Angulo A; Vilches C; Gómez-Lozano N; Malats N; López-Botet M
Blood; 2004 Dec; 104(12):3664-71. PubMed ID: 15304389
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
14. UL40-mediated NK evasion during productive infection with human cytomegalovirus.
Wang EC; McSharry B; Retiere C; Tomasec P; Williams S; Borysiewicz LK; Braud VM; Wilkinson GW
Proc Natl Acad Sci U S A; 2002 May; 99(11):7570-5. PubMed ID: 12032324
[TBL] [Abstract][Full Text] [Related]
15. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.
Béziat V; Dalgard O; Asselah T; Halfon P; Bedossa P; Boudifa A; Hervier B; Theodorou I; Martinot M; Debré P; Björkström NK; Malmberg KJ; Marcellin P; Vieillard V
Eur J Immunol; 2012 Feb; 42(2):447-57. PubMed ID: 22105371
[TBL] [Abstract][Full Text] [Related]
16. The CD94/NKG2C-expressing NK cell subset is augmented in chronic lymphocytic leukemia patients with positive human cytomegalovirus serostatus.
Petersen L; Roug AS; Skovbo A; Thysen AH; Eskelund CW; Hokland ME
Viral Immunol; 2009 Oct; 22(5):333-7. PubMed ID: 19811091
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A
J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
Tanaka J; Toubai T; Miura Y; Tsutsumi Y; Kato N; Umehara S; Toyoshima N; Ohta S; Asaka M; Imamura M
Transplant Proc; 2004 Oct; 36(8):2511-2. PubMed ID: 15561299
[TBL] [Abstract][Full Text] [Related]
20. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
